1 Study Coverage
    1.1 Peptide APIs Product Introduction
    1.2 Market by Type
        1.2.1 Global Peptide APIs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Liquid Phase Peptide Synthesis (LPPS)
        1.2.3 Solid Phase Peptide Synthesis (SPPS)
    1.3 Market by Application
        1.3.1 Global Peptide APIs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Cancer
        1.3.3 Diabetes
        1.3.4 Obesity
        1.3.5 Fertility
        1.3.6 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Peptide APIs Sales Estimates and Forecasts 2017-2028
    2.2 Global Peptide APIs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Peptide APIs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Peptide APIs Sales by Region
        2.4.1 Global Peptide APIs Sales by Region (2017-2022)
        2.4.2 Global Sales Peptide APIs by Region (2023-2028)
    2.5 Global Peptide APIs Revenue by Region
        2.5.1 Global Peptide APIs Revenue by Region (2017-2022)
        2.5.2 Global Peptide APIs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Peptide APIs Sales by Manufacturers
        3.1.1 Global Top Peptide APIs Manufacturers by Sales (2017-2022)
        3.1.2 Global Peptide APIs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Peptide APIs in 2021
    3.2 Global Peptide APIs Revenue by Manufacturers
        3.2.1 Global Peptide APIs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Peptide APIs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Peptide APIs Revenue in 2021
    3.3 Global Peptide APIs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Peptide APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Peptide APIs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Peptide APIs Sales by Type
        4.1.1 Global Peptide APIs Historical Sales by Type (2017-2022)
        4.1.2 Global Peptide APIs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Peptide APIs Sales Market Share by Type (2017-2028)
    4.2 Global Peptide APIs Revenue by Type
        4.2.1 Global Peptide APIs Historical Revenue by Type (2017-2022)
        4.2.2 Global Peptide APIs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Peptide APIs Revenue Market Share by Type (2017-2028)
    4.3 Global Peptide APIs Price by Type
        4.3.1 Global Peptide APIs Price by Type (2017-2022)
        4.3.2 Global Peptide APIs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Peptide APIs Sales by Application
        5.1.1 Global Peptide APIs Historical Sales by Application (2017-2022)
        5.1.2 Global Peptide APIs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Peptide APIs Sales Market Share by Application (2017-2028)
    5.2 Global Peptide APIs Revenue by Application
        5.2.1 Global Peptide APIs Historical Revenue by Application (2017-2022)
        5.2.2 Global Peptide APIs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Peptide APIs Revenue Market Share by Application (2017-2028)
    5.3 Global Peptide APIs Price by Application
        5.3.1 Global Peptide APIs Price by Application (2017-2022)
        5.3.2 Global Peptide APIs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Peptide APIs Market Size by Type
        6.1.1 North America Peptide APIs Sales by Type (2017-2028)
        6.1.2 North America Peptide APIs Revenue by Type (2017-2028)
    6.2 North America Peptide APIs Market Size by Application
        6.2.1 North America Peptide APIs Sales by Application (2017-2028)
        6.2.2 North America Peptide APIs Revenue by Application (2017-2028)
    6.3 North America Peptide APIs Market Size by Country
        6.3.1 North America Peptide APIs Sales by Country (2017-2028)
        6.3.2 North America Peptide APIs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Peptide APIs Market Size by Type
        7.1.1 Europe Peptide APIs Sales by Type (2017-2028)
        7.1.2 Europe Peptide APIs Revenue by Type (2017-2028)
    7.2 Europe Peptide APIs Market Size by Application
        7.2.1 Europe Peptide APIs Sales by Application (2017-2028)
        7.2.2 Europe Peptide APIs Revenue by Application (2017-2028)
    7.3 Europe Peptide APIs Market Size by Country
        7.3.1 Europe Peptide APIs Sales by Country (2017-2028)
        7.3.2 Europe Peptide APIs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Peptide APIs Market Size by Type
        8.1.1 Asia Pacific Peptide APIs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Peptide APIs Revenue by Type (2017-2028)
    8.2 Asia Pacific Peptide APIs Market Size by Application
        8.2.1 Asia Pacific Peptide APIs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Peptide APIs Revenue by Application (2017-2028)
    8.3 Asia Pacific Peptide APIs Market Size by Region
        8.3.1 Asia Pacific Peptide APIs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Peptide APIs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Peptide APIs Market Size by Type
        9.1.1 Latin America Peptide APIs Sales by Type (2017-2028)
        9.1.2 Latin America Peptide APIs Revenue by Type (2017-2028)
    9.2 Latin America Peptide APIs Market Size by Application
        9.2.1 Latin America Peptide APIs Sales by Application (2017-2028)
        9.2.2 Latin America Peptide APIs Revenue by Application (2017-2028)
    9.3 Latin America Peptide APIs Market Size by Country
        9.3.1 Latin America Peptide APIs Sales by Country (2017-2028)
        9.3.2 Latin America Peptide APIs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Peptide APIs Market Size by Type
        10.1.1 Middle East and Africa Peptide APIs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Peptide APIs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Peptide APIs Market Size by Application
        10.2.1 Middle East and Africa Peptide APIs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Peptide APIs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Peptide APIs Market Size by Country
        10.3.1 Middle East and Africa Peptide APIs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Peptide APIs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 CordenPharma
        11.1.1 CordenPharma Corporation Information
        11.1.2 CordenPharma Overview
        11.1.3 CordenPharma Peptide APIs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 CordenPharma Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 CordenPharma Recent Developments
    11.2 PolyPeptide
        11.2.1 PolyPeptide Corporation Information
        11.2.2 PolyPeptide Overview
        11.2.3 PolyPeptide Peptide APIs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 PolyPeptide Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 PolyPeptide Recent Developments
    11.3 Bachem
        11.3.1 Bachem Corporation Information
        11.3.2 Bachem Overview
        11.3.3 Bachem Peptide APIs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Bachem Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Bachem Recent Developments
    11.4 AmbioPharm
        11.4.1 AmbioPharm Corporation Information
        11.4.2 AmbioPharm Overview
        11.4.3 AmbioPharm Peptide APIs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 AmbioPharm Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 AmbioPharm Recent Developments
    11.5 Pepscan
        11.5.1 Pepscan Corporation Information
        11.5.2 Pepscan Overview
        11.5.3 Pepscan Peptide APIs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Pepscan Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Pepscan Recent Developments
    11.6 BCN Peptides
        11.6.1 BCN Peptides Corporation Information
        11.6.2 BCN Peptides Overview
        11.6.3 BCN Peptides Peptide APIs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 BCN Peptides Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 BCN Peptides Recent Developments
    11.7 Senn Chemicals
        11.7.1 Senn Chemicals Corporation Information
        11.7.2 Senn Chemicals Overview
        11.7.3 Senn Chemicals Peptide APIs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Senn Chemicals Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Senn Chemicals Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Peptide APIs Industry Chain Analysis
    12.2 Peptide APIs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Peptide APIs Production Mode & Process
    12.4 Peptide APIs Sales and Marketing
        12.4.1 Peptide APIs Sales Channels
        12.4.2 Peptide APIs Distributors
    12.5 Peptide APIs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Peptide APIs Industry Trends
    13.2 Peptide APIs Market Drivers
    13.3 Peptide APIs Market Challenges
    13.4 Peptide APIs Market Restraints
14 Key Findings in The Global Peptide APIs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Peptide APIs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Liquid Phase Peptide Synthesis (LPPS)
    Table 3. Major Manufacturers of Solid Phase Peptide Synthesis (SPPS)
    Table 4. Global Peptide APIs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Peptide APIs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Peptide APIs Sales by Region (2017-2022) & (K MT)
    Table 7. Global Peptide APIs Sales Market Share by Region (2017-2022)
    Table 8. Global Peptide APIs Sales by Region (2023-2028) & (K MT)
    Table 9. Global Peptide APIs Sales Market Share by Region (2023-2028)
    Table 10. Global Peptide APIs Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Peptide APIs Revenue Market Share by Region (2017-2022)
    Table 12. Global Peptide APIs Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Peptide APIs Revenue Market Share by Region (2023-2028)
    Table 14. Global Peptide APIs Sales by Manufacturers (2017-2022) & (K MT)
    Table 15. Global Peptide APIs Sales Share by Manufacturers (2017-2022)
    Table 16. Global Peptide APIs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Peptide APIs Revenue Share by Manufacturers (2017-2022)
    Table 18. Peptide APIs Price by Manufacturers (2017-2022) &(USD/MT)
    Table 19. Global Peptide APIs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Peptide APIs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide APIs as of 2021)
    Table 21. Peptide APIs Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Peptide APIs Product Offered
    Table 23. Date of Manufacturers Enter into Peptide APIs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Peptide APIs Sales by Type (2017-2022) & (K MT)
    Table 26. Global Peptide APIs Sales by Type (2023-2028) & (K MT)
    Table 27. Global Peptide APIs Sales Share by Type (2017-2022)
    Table 28. Global Peptide APIs Sales Share by Type (2023-2028)
    Table 29. Global Peptide APIs Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Peptide APIs Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Peptide APIs Revenue Share by Type (2017-2022)
    Table 32. Global Peptide APIs Revenue Share by Type (2023-2028)
    Table 33. Peptide APIs Price by Type (2017-2022) & (USD/MT)
    Table 34. Global Peptide APIs Price Forecast by Type (2023-2028) & (USD/MT)
    Table 35. Global Peptide APIs Sales by Application (2017-2022) & (K MT)
    Table 36. Global Peptide APIs Sales by Application (2023-2028) & (K MT)
    Table 37. Global Peptide APIs Sales Share by Application (2017-2022)
    Table 38. Global Peptide APIs Sales Share by Application (2023-2028)
    Table 39. Global Peptide APIs Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Peptide APIs Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Peptide APIs Revenue Share by Application (2017-2022)
    Table 42. Global Peptide APIs Revenue Share by Application (2023-2028)
    Table 43. Peptide APIs Price by Application (2017-2022) & (USD/MT)
    Table 44. Global Peptide APIs Price Forecast by Application (2023-2028) & (USD/MT)
    Table 45. North America Peptide APIs Sales by Type (2017-2022) & (K MT)
    Table 46. North America Peptide APIs Sales by Type (2023-2028) & (K MT)
    Table 47. North America Peptide APIs Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Peptide APIs Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Peptide APIs Sales by Application (2017-2022) & (K MT)
    Table 50. North America Peptide APIs Sales by Application (2023-2028) & (K MT)
    Table 51. North America Peptide APIs Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Peptide APIs Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Peptide APIs Sales by Country (2017-2022) & (K MT)
    Table 54. North America Peptide APIs Sales by Country (2023-2028) & (K MT)
    Table 55. North America Peptide APIs Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Peptide APIs Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Peptide APIs Sales by Type (2017-2022) & (K MT)
    Table 58. Europe Peptide APIs Sales by Type (2023-2028) & (K MT)
    Table 59. Europe Peptide APIs Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Peptide APIs Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Peptide APIs Sales by Application (2017-2022) & (K MT)
    Table 62. Europe Peptide APIs Sales by Application (2023-2028) & (K MT)
    Table 63. Europe Peptide APIs Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Peptide APIs Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Peptide APIs Sales by Country (2017-2022) & (K MT)
    Table 66. Europe Peptide APIs Sales by Country (2023-2028) & (K MT)
    Table 67. Europe Peptide APIs Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Peptide APIs Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Peptide APIs Sales by Type (2017-2022) & (K MT)
    Table 70. Asia Pacific Peptide APIs Sales by Type (2023-2028) & (K MT)
    Table 71. Asia Pacific Peptide APIs Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Peptide APIs Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Peptide APIs Sales by Application (2017-2022) & (K MT)
    Table 74. Asia Pacific Peptide APIs Sales by Application (2023-2028) & (K MT)
    Table 75. Asia Pacific Peptide APIs Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Peptide APIs Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Peptide APIs Sales by Region (2017-2022) & (K MT)
    Table 78. Asia Pacific Peptide APIs Sales by Region (2023-2028) & (K MT)
    Table 79. Asia Pacific Peptide APIs Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Peptide APIs Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Peptide APIs Sales by Type (2017-2022) & (K MT)
    Table 82. Latin America Peptide APIs Sales by Type (2023-2028) & (K MT)
    Table 83. Latin America Peptide APIs Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Peptide APIs Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Peptide APIs Sales by Application (2017-2022) & (K MT)
    Table 86. Latin America Peptide APIs Sales by Application (2023-2028) & (K MT)
    Table 87. Latin America Peptide APIs Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Peptide APIs Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Peptide APIs Sales by Country (2017-2022) & (K MT)
    Table 90. Latin America Peptide APIs Sales by Country (2023-2028) & (K MT)
    Table 91. Latin America Peptide APIs Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Peptide APIs Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Peptide APIs Sales by Type (2017-2022) & (K MT)
    Table 94. Middle East and Africa Peptide APIs Sales by Type (2023-2028) & (K MT)
    Table 95. Middle East and Africa Peptide APIs Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Peptide APIs Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Peptide APIs Sales by Application (2017-2022) & (K MT)
    Table 98. Middle East and Africa Peptide APIs Sales by Application (2023-2028) & (K MT)
    Table 99. Middle East and Africa Peptide APIs Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Peptide APIs Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Peptide APIs Sales by Country (2017-2022) & (K MT)
    Table 102. Middle East and Africa Peptide APIs Sales by Country (2023-2028) & (K MT)
    Table 103. Middle East and Africa Peptide APIs Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Peptide APIs Revenue by Country (2023-2028) & (US$ Million)
    Table 105. CordenPharma Corporation Information
    Table 106. CordenPharma Description and Major Businesses
    Table 107. CordenPharma Peptide APIs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 108. CordenPharma Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. CordenPharma Recent Developments
    Table 110. PolyPeptide Corporation Information
    Table 111. PolyPeptide Description and Major Businesses
    Table 112. PolyPeptide Peptide APIs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 113. PolyPeptide Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. PolyPeptide Recent Developments
    Table 115. Bachem Corporation Information
    Table 116. Bachem Description and Major Businesses
    Table 117. Bachem Peptide APIs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 118. Bachem Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Bachem Recent Developments
    Table 120. AmbioPharm Corporation Information
    Table 121. AmbioPharm Description and Major Businesses
    Table 122. AmbioPharm Peptide APIs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 123. AmbioPharm Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. AmbioPharm Recent Developments
    Table 125. Pepscan Corporation Information
    Table 126. Pepscan Description and Major Businesses
    Table 127. Pepscan Peptide APIs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 128. Pepscan Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Pepscan Recent Developments
    Table 130. BCN Peptides Corporation Information
    Table 131. BCN Peptides Description and Major Businesses
    Table 132. BCN Peptides Peptide APIs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 133. BCN Peptides Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. BCN Peptides Recent Developments
    Table 135. Senn Chemicals Corporation Information
    Table 136. Senn Chemicals Description and Major Businesses
    Table 137. Senn Chemicals Peptide APIs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 138. Senn Chemicals Peptide APIs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Senn Chemicals Recent Developments
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Peptide APIs Distributors List
    Table 143. Peptide APIs Customers List
    Table 144. Peptide APIs Market Trends
    Table 145. Peptide APIs Market Drivers
    Table 146. Peptide APIs Market Challenges
    Table 147. Peptide APIs Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Peptide APIs Product Picture
    Figure 3. Global Peptide APIs Market Share by Type in 2021 & 2028
    Figure 3. Liquid Phase Peptide Synthesis (LPPS) Product Picture
    Figure 4. Solid Phase Peptide Synthesis (SPPS) Product Picture
    Figure 5. Global Peptide APIs Market Share by Application in 2021 & 2028
    Figure 6. Cancer
    Figure 7. Diabetes
    Figure 8. Obesity
    Figure 9. Fertility
    Figure 10. Other
    Figure 11. Peptide APIs Report Years Considered
    Figure 12. Global Peptide APIs Sales 2017-2028 (K MT)
    Figure 13. Global Peptide APIs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Peptide APIs Revenue 2017-2028 (US$ Million)
    Figure 15. Global Peptide APIs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Peptide APIs Sales Market Share by Region (2017-2022)
    Figure 17. Global Peptide APIs Sales Market Share by Region (2023-2028)
    Figure 18. North America Peptide APIs Sales YoY (2017-2028) & (K MT)
    Figure 19. North America Peptide APIs Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Peptide APIs Sales YoY (2017-2028) & (K MT)
    Figure 21. Europe Peptide APIs Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Peptide APIs Sales YoY (2017-2028) & (K MT)
    Figure 23. Asia-Pacific Peptide APIs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Peptide APIs Sales YoY (2017-2028) & (K MT)
    Figure 25. Latin America Peptide APIs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Peptide APIs Sales YoY (2017-2028) & (K MT)
    Figure 27. Middle East & Africa Peptide APIs Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Peptide APIs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Peptide APIs in the World: Market Share by Peptide APIs Revenue in 2021
    Figure 30. Global Peptide APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Peptide APIs Sales Market Share by Type (2017-2028)
    Figure 32. Global Peptide APIs Revenue Market Share by Type (2017-2028)
    Figure 33. Global Peptide APIs Sales Market Share by Application (2017-2028)
    Figure 34. Global Peptide APIs Revenue Market Share by Application (2017-2028)
    Figure 35. North America Peptide APIs Sales Market Share by Type (2017-2028)
    Figure 36. North America Peptide APIs Revenue Market Share by Type (2017-2028)
    Figure 37. North America Peptide APIs Sales Market Share by Application (2017-2028)
    Figure 38. North America Peptide APIs Revenue Market Share by Application (2017-2028)
    Figure 39. North America Peptide APIs Sales Share by Country (2017-2028)
    Figure 40. North America Peptide APIs Revenue Share by Country (2017-2028)
    Figure 41. U.S. Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Peptide APIs Sales Market Share by Type (2017-2028)
    Figure 44. Europe Peptide APIs Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Peptide APIs Sales Market Share by Application (2017-2028)
    Figure 46. Europe Peptide APIs Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Peptide APIs Sales Share by Country (2017-2028)
    Figure 48. Europe Peptide APIs Revenue Share by Country (2017-2028)
    Figure 49. Germany Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 50. France Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Peptide APIs Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Peptide APIs Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Peptide APIs Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Peptide APIs Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Peptide APIs Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Peptide APIs Revenue Share by Region (2017-2028)
    Figure 60. China Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 63. India Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Peptide APIs Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Peptide APIs Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Peptide APIs Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Peptide APIs Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Peptide APIs Sales Share by Country (2017-2028)
    Figure 75. Latin America Peptide APIs Revenue Share by Country (2017-2028)
    Figure 76. Mexico Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Peptide APIs Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Peptide APIs Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Peptide APIs Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Peptide APIs Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Peptide APIs Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Peptide APIs Revenue Share by Country (2017-2028)
    Figure 85. Turkey Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Peptide APIs Revenue (2017-2028) & (US$ Million)
    Figure 88. Peptide APIs Value Chain
    Figure 89. Peptide APIs Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed